These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
148 related articles for article (PubMed ID: 27077114)
1. An Eighteen-Gene Classifier Predicts Locoregional Recurrence in Post-Mastectomy Breast Cancer Patients. Cheng SH; Horng CF; Huang TT; Huang ES; Tsou MH; Shi LS; Yu BL; Chen CM; Huang AT EBioMedicine; 2016 Mar; 5():74-81. PubMed ID: 27077114 [TBL] [Abstract][Full Text] [Related]
2. Genomic prediction of locoregional recurrence after mastectomy in breast cancer. Cheng SH; Horng CF; West M; Huang E; Pittman J; Tsou MH; Dressman H; Chen CM; Tsai SY; Jian JJ; Liu MC; Nevins JR; Huang AT J Clin Oncol; 2006 Oct; 24(28):4594-602. PubMed ID: 17008701 [TBL] [Abstract][Full Text] [Related]
3. Selecting breast cancer patients with T1-T2 tumors and one to three positive axillary nodes at high postmastectomy locoregional recurrence risk for adjuvant radiotherapy. Truong PT; Olivotto IA; Kader HA; Panades M; Speers CH; Berthelet E Int J Radiat Oncol Biol Phys; 2005 Apr; 61(5):1337-47. PubMed ID: 15817335 [TBL] [Abstract][Full Text] [Related]
4. Gene expression profiling to predict the risk of locoregional recurrence in breast cancer: a pooled analysis. Drukker CA; Elias SG; Nijenhuis MV; Wesseling J; Bartelink H; Elkhuizen P; Fowble B; Whitworth PW; Patel RR; de Snoo FA; van 't Veer LJ; Beitsch PD; Rutgers EJ Breast Cancer Res Treat; 2014 Dec; 148(3):599-613. PubMed ID: 25414025 [TBL] [Abstract][Full Text] [Related]
5. Ten-year locoregional recurrence risks in women with nodal micrometastatic breast cancer staged with axillary dissection. Lupe K; Truong PT; Alexander C; Speers C; Tyldesley S Int J Radiat Oncol Biol Phys; 2011 Dec; 81(5):e681-8. PubMed ID: 21300456 [TBL] [Abstract][Full Text] [Related]
6. 21-Gene Recurrence Score Assay Predicts Benefit of Post-Mastectomy Radiotherapy in T1-2 N1 Breast Cancer. Goodman CR; Seagle BL; Kocherginsky M; Donnelly ED; Shahabi S; Strauss JB Clin Cancer Res; 2018 Aug; 24(16):3878-3887. PubMed ID: 29685878 [No Abstract] [Full Text] [Related]
7. Postmastectomy radiotherapy improves disease-free survival of high risk of locoregional recurrence breast cancer patients with T1-2 and 1 to 3 positive nodes. He ZY; Wu SG; Zhou J; Li FY; Lin Q; Lin HX; Sun JY PLoS One; 2015; 10(3):e0119105. PubMed ID: 25781605 [TBL] [Abstract][Full Text] [Related]
8. A positive margin is not always an indication for radiotherapy after mastectomy in early breast cancer. Truong PT; Olivotto IA; Speers CH; Wai ES; Berthelet E; Kader HA Int J Radiat Oncol Biol Phys; 2004 Mar; 58(3):797-804. PubMed ID: 14967436 [TBL] [Abstract][Full Text] [Related]
9. The Effect of Adjuvant Trastuzumab on Locoregional Recurrence of Human Epidermal Growth Factor Receptor 2-Positive Breast Cancer Treated with Mastectomy. Lanning RM; Morrow M; Riaz N; McArthur HL; Dang C; Moo TA; El-Tamer M; Krause K; Siu C; Hsu M; Zhang Z; Pei X; McCormick B; Powell SN; Ho A Ann Surg Oncol; 2015 Aug; 22(8):2517-25. PubMed ID: 25564167 [TBL] [Abstract][Full Text] [Related]
10. The Effect of Molecular Subtype and Residual Disease on Locoregional Recurrence in Breast Cancer Patients Treated with Neoadjuvant Chemotherapy and Postmastectomy Radiation. Yang TJ; Morrow M; Modi S; Zhang Z; Krause K; Siu C; McCormick B; Powell SN; Ho AY Ann Surg Oncol; 2015 Dec; 22 Suppl 3(Suppl 3):S495-501. PubMed ID: 26130454 [TBL] [Abstract][Full Text] [Related]
11. Prognostic index score and clinical prediction model of local regional recurrence after mastectomy in breast cancer patients. Cheng SH; Horng CF; Clarke JL; Tsou MH; Tsai SY; Chen CM; Jian JJ; Liu MC; West M; Huang AT; Prosnitz LR Int J Radiat Oncol Biol Phys; 2006 Apr; 64(5):1401-9. PubMed ID: 16472935 [TBL] [Abstract][Full Text] [Related]
12. Selection criteria for postmastectomy radiotherapy in t1-t2 tumors with 1 to 3 positive lymph nodes. Moo TA; McMillan R; Lee M; Stempel M; Patil S; Ho A; El-Tamer M Ann Surg Oncol; 2013 Oct; 20(10):3169-74. PubMed ID: 23975289 [TBL] [Abstract][Full Text] [Related]
13. Locoregional recurrence risk factors and the impact of postmastectomy radiotherapy on patients with tumors 5 cm or larger. Nagao T; Kinoshita T; Tamura N; Hojo T; Morota M; Kagami Y Breast Cancer; 2014 May; 21(3):292-301. PubMed ID: 22890603 [TBL] [Abstract][Full Text] [Related]
14. Risk factors for locoregional recurrence after mastectomy in stage T1 N0 breast cancer. Hastings J; Iganej S; Huang C; Huang R; Slezak J Am J Clin Oncol; 2014 Oct; 37(5):486-91. PubMed ID: 23428949 [TBL] [Abstract][Full Text] [Related]
15. Development and validation of a gene profile predicting benefit of postmastectomy radiotherapy in patients with high-risk breast cancer: a study of gene expression in the DBCG82bc cohort. Tramm T; Mohammed H; Myhre S; Kyndi M; Alsner J; Børresen-Dale AL; Sørlie T; Frigessi A; Overgaard J Clin Cancer Res; 2014 Oct; 20(20):5272-80. PubMed ID: 25149560 [TBL] [Abstract][Full Text] [Related]
16. Patients with t1 to t2 breast cancer with one to three positive nodes have higher local and regional recurrence risks compared with node-negative patients after breast-conserving surgery and whole-breast radiotherapy. Truong PT; Jones SO; Kader HA; Wai ES; Speers CH; Alexander AS; Olivotto IA Int J Radiat Oncol Biol Phys; 2009 Feb; 73(2):357-64. PubMed ID: 18676091 [TBL] [Abstract][Full Text] [Related]
17. Identification and validation of single-sample breast cancer radiosensitivity gene expression predictors. Sjöström M; Staaf J; Edén P; Wärnberg F; Bergh J; Malmström P; Fernö M; Niméus E; Fredriksson I Breast Cancer Res; 2018 Jul; 20(1):64. PubMed ID: 29973242 [TBL] [Abstract][Full Text] [Related]
18. Influence of lymphatic invasion on locoregional recurrence following mastectomy: indication for postmastectomy radiotherapy for breast cancer patients with one to three positive nodes. Matsunuma R; Oguchi M; Fujikane T; Matsuura M; Sakai T; Kimura K; Morizono H; Iijima K; Izumori A; Miyagi Y; Nishimura S; Makita M; Gomi N; Horii R; Akiyama F; Iwase T Int J Radiat Oncol Biol Phys; 2012 Jul; 83(3):845-52. PubMed ID: 22138460 [TBL] [Abstract][Full Text] [Related]
19. Chest wall radiotherapy: middle ground for treatment of patients with one to three positive lymph nodes after mastectomy. Macdonald SM; Abi-Raad RF; Alm El-Din MA; Niemierko A; Kobayashi W; McGrath JJ; Goldberg SI; Powell S; Smith B; Taghian AG Int J Radiat Oncol Biol Phys; 2009 Dec; 75(5):1297-303. PubMed ID: 19327896 [TBL] [Abstract][Full Text] [Related]
20. Biological Subtype Predicts Risk of Locoregional Recurrence After Mastectomy and Impact of Postmastectomy Radiation in a Large National Database. Tseng YD; Uno H; Hughes ME; Niland JC; Wong YN; Theriault R; Blitzblau RC; Moy B; Breslin T; Edge SB; Hassett MJ; Punglia RS Int J Radiat Oncol Biol Phys; 2015 Nov; 93(3):622-30. PubMed ID: 26461004 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]